Genistein ameliorates hyperglycemia in a mouse model of nongenetic type 2 diabetes
-
- Zhuo Fu
- Department of Human Nutrition, Foods and Exercise, Virginia Tech Blacksburg, VA 24061, USA.
-
- Elizabeth R. Gilbert
- Department of Human Nutrition, Foods and Exercise, Virginia Tech Blacksburg, VA 24061, USA.
-
- Liliane Pfeiffer
- Department of Human Nutrition, Foods and Exercise, Virginia Tech Blacksburg, VA 24061, USA.
-
- Yanling Zhang
- Department of Human Nutrition, Foods and Exercise, Virginia Tech Blacksburg, VA 24061, USA.
-
- Yu Fu
- Department of Human Nutrition, Foods and Exercise, Virginia Tech Blacksburg, VA 24061, USA.
-
- Dongmin Liu
- Department of Human Nutrition, Foods and Exercise, Virginia Tech Blacksburg, VA 24061, USA.
説明
<jats:p> While peripheral insulin resistance is common during obesity and aging in mice and people, the progression to type 2 diabetes (T2D) is largely due to loss of β-cell mass and function through apoptosis. We recently reported that genistein, a soy derived isoflavone, can improve glycemic control and β-cell function in insulin-deficient diabetic mice. However, whether it can prevent β-cell loss and diabetes in T2D mice is unknown. Our current study aimed to investigate the effect of dietary supplemented genistein in a nongenetic T2D mouse model. Nongenetic, middle-aged obese diabetic mice were generated by high fat diet and a low dose of streptozotocin injection. The effect of dietary supplementation of genistein on glycemic control and β-cell mass and function was determined. Dietary intake of genistein (250 mg·kg<jats:sup>–1</jats:sup> diet) improved hyperglycemia, glucose tolerance, and blood insulin level in obese diabetic mice, whereas it did not affect body weight gain, food intake, fat deposit, plasma lipid profile, and peripheral insulin sensitivity. Genistein increased the number of insulin-positive β-cell in islets, promoted islet β-cell survival, and preserved islet mass. In conclusion, dietary intake of genistein could prevent T2D via a direct protective action on β-cells without alteration of periphery insulin sensitivity. </jats:p>
収録刊行物
-
- Applied Physiology, Nutrition, and Metabolism
-
Applied Physiology, Nutrition, and Metabolism 37 (3), 480-488, 2012-06
Canadian Science Publishing
